Standard operating procedure for arrangements for handling of conflicts of interests for European Medicines Agency scientific meetings
Presentation - European Shortages Monitoring Platform (ESMP) essentials and industry reporting requirements webinar
Scientific recommendations on classification of advanced therapy medicinal products
Scientific recommendations on classification of advanced therapy medicinal products
Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Date of authorisation: 10/05/2012, Revision: 23, Status: Expired
Aplidin
Agenda - Public webinar on pack size submissions: from XEVMPD to product management service (PMS)
Human medicines European public assessment report (EPAR): Zevalin, ibritumomab tiuxetan, Date of authorisation: 16/01/2004, Revision: 23, Status: Lapsed
Opinion/decision on a Paediatric investigation plan (PIP): onivyde, irinotecan, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Oncology, PIP number: P/0241/2023
EMEA-003408-PIP01-23